Table 2: The risk of thromboembolism and bleeding in patients with and without AF.

Patients without AF Patients with AF p value
CHA2DS2-VASc score
CHF, n
AH, n
≥75 y., n
65-74 y., n
Stroke/ TIA/ TE history, n
PVD/ MI history, n
DM, n
Female, n
3 (0-7)
6
84
28
32
18
12
23
39
4 (1-8)
9
99
55
34
22
16
8
63
<0.001
0.421
<0.001
<0.001
0.764
0.480
0.415
0.003
0.002
HAS-BLED score
AH, n
RD/ LD, n
Prior stroke, n
Major bleeding history, n
Labile INR, n
>65 y., n
Drugs/ alcohol, n
2 (0-4)
84
3
11
0
0
57
18
2 (1-4)
99
9
18
0
0
88
18
<0.001
<0.001
0.150
0.160
-
-
<0.001
0.493

AF-atrial fibrillation; CHF-congestive heart failure; AH-hypertension; TIA-transient ischemic attack; TE-thromboembolism; PVD-peripheral vascular disease; MI-myocardial infarction; DM-diabetes mellitus; RD-renal disease; LD-liver disease; INR - international normalized ratio.